Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Porta

Showing results (251-260 of 388) with videos related to

Pageof 39
Sort By:
International Journal of Molecular Sciences|April 23, 2022
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder CancerNicola Antonio di Meo, Davide Loizzo, Savio Domenico Pandolfo, et al.
Lancet (London, England)|July 26, 2008
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialRobert J Motzer, Bernard Escudier, Stéphane Oudard, et al.
Future Oncology (London, England)|January 29, 2019
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationaleViktor Grünwald, Thomas Powles, Toni K Choueiri, et al.
The Lancet. Oncology|July 21, 2009
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trialMartin E Gore, Cezary Szczylik, Camillo Porta, et al.
European Urology Oncology|February 9, 2025
Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi StudyLaurence Albiges, Marine Gross-Goupil, Philippe Barthélémy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2017
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signatureFrancesco Moccia, Vittoria Fotia, Richard Tancredi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2025
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi studyViktor Grünwald, Axel Bex, Sylvie Rottey, et al.
World Journal of Gastroenterology|April 22, 2017
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinomaLorenza Rimassa, Maria Reig, Giovanni Abbadessa, et al.
Oncotarget|October 15, 2016
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approachMichelangelo Fiorentino, Elisa Gruppioni, Francesco Massari, et al.
Metabolites|December 16, 2020
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell CarcinomaGiuseppe Lucarelli, Matteo Ferro, Davide Loizzo, et al.
Pageof 39

Showing results (251-260 of 388) with videos related to

Sort By:
Pageof 39
International Journal of Molecular Sciences|April 23, 2022
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder CancerNicola Antonio di Meo, Davide Loizzo, Savio Domenico Pandolfo, et al.
Lancet (London, England)|July 26, 2008
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialRobert J Motzer, Bernard Escudier, Stéphane Oudard, et al.
Future Oncology (London, England)|January 29, 2019
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationaleViktor Grünwald, Thomas Powles, Toni K Choueiri, et al.
The Lancet. Oncology|July 21, 2009
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trialMartin E Gore, Cezary Szczylik, Camillo Porta, et al.
European Urology Oncology|February 9, 2025
Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi StudyLaurence Albiges, Marine Gross-Goupil, Philippe Barthélémy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2017
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signatureFrancesco Moccia, Vittoria Fotia, Richard Tancredi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2025
Current status of adjuvant immunotherapy and relapse management in renal cell carcinoma: Insights from a European delphi studyViktor Grünwald, Axel Bex, Sylvie Rottey, et al.
World Journal of Gastroenterology|April 22, 2017
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinomaLorenza Rimassa, Maria Reig, Giovanni Abbadessa, et al.
Oncotarget|October 15, 2016
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approachMichelangelo Fiorentino, Elisa Gruppioni, Francesco Massari, et al.
Metabolites|December 16, 2020
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell CarcinomaGiuseppe Lucarelli, Matteo Ferro, Davide Loizzo, et al.
Pageof 39